Abstract
Describe the epidemiology of heart failure in people with diabetes mellitus. Implement evidence-based nonpharmacologic and pharmacologic therapies for heart failure with preserved ejection fraction and heart failure with reduced ejection fraction as recommended in current guidelines. Characterize the role of glucose-lowering medications, focusing on the sodium glucose cotransporter-2 inhibitors, for the treatment of people with type 2 diabetes mellitus.
| Original language | English (US) |
|---|---|
| Pages (from-to) | S27-S32 |
| Journal | The Journal of family practice |
| Volume | 69 |
| Issue number | 7 |
| State | Published - Sep 1 2020 |
ASJC Scopus subject areas
- General Medicine